Literature DB >> 10505692

Antagonistic effects of vitamin D and parathyroid hormone on lipoprotein lipase in cultured adipocytes.

U Querfeld1, M M Hoffmann, G Klaus, F Eifinger, M Ackerschott, D Michalk, P A Kern.   

Abstract

The effects of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) (calcitriol) and parathyroid hormone (PTH) on synthesis and secretion of lipoprotein lipase (LPL) were studied in 3T3-L1 adipocytes. Expression of the vitamin D receptor was demonstrated by saturation kinetics with radiolabeled calcitriol. Incubation with calcitriol (10(-8) M) for up to 4 d resulted in a time-dependent significant increase in heparin-releasable LPL activity (LPLa) accompanied by a significant increase in LPL mRNA. In contrast, incubation with intact (1-84) PTH (10(-6) to 10(-9) M) produced a time- and dose-dependent significant decrease in LPLa, but no change in LPL mRNA. The effect of PTH (24-h incubation, 10(-8) M) could be prevented by the calcium channel blocker verapamil. Coincubation with both calcitriol and PTH at equimolar concentration (10(-8) M) resulted in an increase in LPLa and LPL mRNA. These data indicate an antagonistic role for calcitriol and PTH in the regulation of LPL, possibly mediated by intracellular calcium, which may contribute to the alterations in lipoprotein metabolism occurring in uremia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10505692     DOI: 10.1681/ASN.V10102158

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  30 in total

1.  Lipid accumulation product and 25-OH-vitamin D deficiency in type 2 diabetes.

Authors:  Gianluca Bardini; Stefano Giannini; Desiderio Romano; Carlo M Rotella; Edoardo Mannucci
Journal:  Rev Diabet Stud       Date:  2014-02-10

2.  Vitamin D and Atherosclerotic Cardiovascular Disease.

Authors:  Thomas Hiemstra; Kenneth Lim; Ravi Thadhani; JoAnn E Manson
Journal:  J Clin Endocrinol Metab       Date:  2019-04-04       Impact factor: 5.958

Review 3.  The Endocrine Role of Bone in Cardiometabolic Health.

Authors:  Rosemary DeLuccia; May Cheung; Rohit Ramadoss; Abeer Aljahdali; Deeptha Sukumar
Journal:  Curr Nutr Rep       Date:  2019-09

Review 4.  Extraskeletal actions of vitamin D.

Authors:  Daniel D Bikle
Journal:  Ann N Y Acad Sci       Date:  2016-07       Impact factor: 5.691

Review 5.  Causes of Vitamin D Deficiency and Effect of Vitamin D Supplementation on Metabolic Complications in Obesity: a Review.

Authors:  Louise Wamberg; Steen B Pedersen; Lars Rejnmark; Bjørn Richelsen
Journal:  Curr Obes Rep       Date:  2015-12

Review 6.  Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window.

Authors:  Uwe Querfeld; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2010-06-22       Impact factor: 3.714

7.  Vitamin D Receptor Gene Haplotype and Late-Onset Obesity in Iranian Azeri Turkish Women.

Authors:  Morteza Bagheri; Fatemeh Bahadori; Shahsanam Gheibi; Tahereh Behrooz Lak; Zahra Kuse-Lu; Zahra Sahebozamani; Isa Abdi-Rad
Journal:  Maedica (Buchar)       Date:  2017-06

8.  The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases.

Authors:  Marie-France Nissou; Jacques Brocard; Michèle El Atifi; Audrey Guttin; Annie Andrieux; François Berger; Jean-Paul Issartel; Didier Wion
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  Relationship between 25 hydroxyvitamin D and lipid profile in Lebanese school children.

Authors:  M H Gannagé-Yared; R Sabbagh; R Chédid
Journal:  J Endocrinol Invest       Date:  2018-02-06       Impact factor: 4.256

10.  Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial.

Authors:  Lars Rejnmark; Peter Vestergaard; Lene Heickendorff; Leif Mosekilde
Journal:  Int J Endocrinol       Date:  2009-07-21       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.